A new drug has shown promise in halting the development of Alzheimer's disease in a trial. The treatment may potentially reverse cognitive decline, although it is unclear if this applies to humans or just animal models. Reports on the specifics of the breakthrough and its applications vary, with some mentioning a new trigger for the disease and others discussing different conditions altogether.